Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic

Circulation

Volumn 103, Issue 15, 2001, Pages 2004-2013

  Hondeghem, L M ^a,b,c   Carlsson, L ^a,b   Duker, G ^a,b  

^a Department of Pharmacology ^*  (Belgium)

^b ASTRAZENECA R AND D   (Sweden)

^c NONE   (Belgium)

Author keywords

Action potentials; Antiarrhythmia agents; Arrhythmia; Drugs; Torsade de pointes

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; EXTRASYSTOLE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART PROARRHYTHMIA; HEART REPOLARIZATION; MALE; MUSCLE ACTION POTENTIAL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RABBIT; TORSADE DES POINTES;

EID: 0035901578     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.15.2004     Document Type: Article

References (32)

1. Mechanisms and management of proarrhythmia
2. Computer aided development of antiarrhythmic agents with class IIIa properties
3. Proarrhythmic effects of the class III agent almokalant: Importance of infusion rate, QT dispersion, and early afterdepolarisations
4. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: Etiology and interventions
5. + current by almokalant in rabbit ventricular myocytes
6. Cardiac electrical restitution properties and stability of reentrant spiral waves: A simulation study
7. Chaos and the transition to ventricular fibrillation: A new approach to antiarrhythmic drug evaluation
8. Ks heterogeneity on action potential duration and its rate dependence: A simulation study
9. Cellular arrhythmogenic effects of congenital and acquired long-QT syndrome in the heterogeneous myocardium
10. Triggered activity in the heart: Cellular mechanisms of early after-depolarizations
11. The effects of quinidine and verapamil on electrically induced automaticity in the ventricular myocardium of guinea pig
12. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone
13. Amiodarone blocks calcium current in single guinea pig ventricular myocytes
14. Amiodarone blocks inactivated cardiac sodium channels
15. Amiodarone-associated proarrhythmic effects: A review with special reference to torsade de pointes tachycardia
16. Proarrhythmic response to sodium channel blockade: Theoretical model and numerical experiments
17. Rapid and slow components of delayed rectifier current in human atrial myocytes
18. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels
19. Antiarrhythmic agents: The modulated receptor mechanism of action of sodium and calcium channel-blocking drugs
20. Antiarrhythmic drugs and cardiac ion channels: Mechanisms of action
21. Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling
22. Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use dependence
23. The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart
24. Beat-to-beat repolarization lability identifies patients at risk for sudden death
25. Temporal repolarization lability in hypertrophic cardiomyopathy caused by β-myosin heavy-chain gene mutations
26. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy
27. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy
28. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: A prospective study